Transaction · 0001628280-26-060911

Loeillot Olivier

Loeillot Olivier, CEO, reported an open-market or private sale at REPLIGEN CORP involving 3035.000000 shares for an estimated $503506.50. Reported holdings after the transaction were 48369.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCEO
RGENREPLIGEN CORP
Filing timeSep 08
Trade dateSep 04, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$168.53
Pre-filing
1mo ago -5.9%1w ago +4.6%1d ago +0.6%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

RGEN price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RGEN since 2026-09-08Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001628280-26-060911
Common Stock
Transaction date
Sep 04, 2026
Filed Sep 08, 2026, 08:13 PM · 4d delay
Shares
3.03k sh
$16.5k per share
Estimated value
-$50.3M
Computed from shares × price
Holdings after
48.3k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Repeat Seller 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

  2. F2

    The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025.

Original filing · 0001628280-26-060911
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RGEN